vs
Side-by-side financial comparison of LENSAR, Inc. (LNSR) and Maase Inc. (MAAS). Click either name above to swap in a different company.
LENSAR, Inc. is the larger business by last-quarter revenue ($14.3M vs $9.9M, roughly 1.4× Maase Inc.).
LENSAR, Inc. is a medical technology company specializing in the development and commercialization of advanced ophthalmic surgical systems. Its proprietary augmented reality-enabled devices deliver high precision for cataract surgery and refractive lens exchange procedures, distributed to ophthalmology clinics, surgical centers and hospitals across North America, Europe and key Asia-Pacific markets.
LNSR vs MAAS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2023
| Metric | | |
|---|---|---|
| Revenue | $14.3M | $9.9M |
| Net Profit | $-1.5M | — |
| Gross Margin | 36.6% | 78.7% |
| Operating Margin | -34.3% | -55.9% |
| Net Margin | -10.2% | — |
| Revenue YoY | -3.3% | — |
| Net Profit YoY | 92.2% | — |
| EPS (diluted) | $-0.09 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $14.3M | — | ||
| Q3 25 | $12.8M | — | ||
| Q2 25 | $12.3M | — | ||
| Q1 25 | $12.3M | — | ||
| Q4 24 | $14.8M | — | ||
| Q3 24 | $11.8M | — | ||
| Q2 24 | $10.7M | — | ||
| Q1 24 | $8.6M | — |
| Q4 25 | $-1.5M | — | ||
| Q3 25 | $-3.7M | — | ||
| Q2 25 | $-1.8M | — | ||
| Q1 25 | $-27.3M | — | ||
| Q4 24 | $-18.7M | — | ||
| Q3 24 | $-1.5M | — | ||
| Q2 24 | $-9.0M | — | ||
| Q1 24 | $-2.2M | — |
| Q4 25 | 36.6% | — | ||
| Q3 25 | 35.1% | — | ||
| Q2 25 | 43.8% | — | ||
| Q1 25 | 42.7% | — | ||
| Q4 24 | 35.1% | — | ||
| Q3 24 | 38.4% | — | ||
| Q2 24 | 45.5% | — | ||
| Q1 24 | 43.0% | — |
| Q4 25 | -34.3% | — | ||
| Q3 25 | -59.4% | — | ||
| Q2 25 | -51.2% | — | ||
| Q1 25 | -47.2% | — | ||
| Q4 24 | -8.7% | — | ||
| Q3 24 | -10.5% | — | ||
| Q2 24 | -49.4% | — | ||
| Q1 24 | -33.0% | — |
| Q4 25 | -10.2% | — | ||
| Q3 25 | -29.1% | — | ||
| Q2 25 | -14.4% | — | ||
| Q1 25 | -222.8% | — | ||
| Q4 24 | -126.2% | — | ||
| Q3 24 | -12.7% | — | ||
| Q2 24 | -84.6% | — | ||
| Q1 24 | -25.0% | — |
| Q4 25 | $-0.09 | — | ||
| Q3 25 | $-0.31 | — | ||
| Q2 25 | $-0.15 | — | ||
| Q1 25 | $-2.32 | — | ||
| Q4 24 | $-1.62 | — | ||
| Q3 24 | $-0.13 | — | ||
| Q2 24 | $-0.79 | — | ||
| Q1 24 | $-0.19 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.0M | $10.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-26.0M | $31.6M |
| Total Assets | $71.4M | $47.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.0M | — | ||
| Q3 25 | $16.9M | — | ||
| Q2 25 | $20.3M | — | ||
| Q1 25 | $25.2M | — | ||
| Q4 24 | $22.5M | — | ||
| Q3 24 | $18.1M | — | ||
| Q2 24 | $14.2M | — | ||
| Q1 24 | $17.9M | — |
| Q4 25 | $-26.0M | — | ||
| Q3 25 | $-25.9M | — | ||
| Q2 25 | $-23.1M | — | ||
| Q1 25 | $-22.1M | — | ||
| Q4 24 | $4.9M | — | ||
| Q3 24 | $22.7M | — | ||
| Q2 24 | $23.6M | — | ||
| Q1 24 | $31.8M | — |
| Q4 25 | $71.4M | — | ||
| Q3 25 | $70.2M | — | ||
| Q2 25 | $70.4M | — | ||
| Q1 25 | $73.0M | — | ||
| Q4 24 | $66.3M | — | ||
| Q3 24 | $62.0M | — | ||
| Q2 24 | $61.4M | — | ||
| Q1 24 | $66.1M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $618.0K | $-18.2M |
| Free Cash FlowOCF − Capex | — | $-18.3M |
| FCF MarginFCF / Revenue | — | -184.4% |
| Capex IntensityCapex / Revenue | 0.0% | 1.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $618.0K | — | ||
| Q3 25 | $-3.5M | — | ||
| Q2 25 | $-5.0M | — | ||
| Q1 25 | $-6.9M | — | ||
| Q4 24 | $3.7M | — | ||
| Q3 24 | $3.2M | — | ||
| Q2 24 | $-3.8M | — | ||
| Q1 24 | $-5.3M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-5.1M | — | ||
| Q1 25 | $-6.9M | — | ||
| Q4 24 | $3.7M | — | ||
| Q3 24 | $3.1M | — | ||
| Q2 24 | $-3.9M | — | ||
| Q1 24 | $-5.3M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -41.3% | — | ||
| Q1 25 | -56.6% | — | ||
| Q4 24 | 24.7% | — | ||
| Q3 24 | 26.5% | — | ||
| Q2 24 | -36.4% | — | ||
| Q1 24 | -61.6% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 0.2% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LNSR
| Products | $12.7M | 89% |
| Services | $1.6M | 11% |
MAAS
| Wealth management | $7.8M | 78% |
| Insurance consulting | $1.0M | 10% |
| Other | $975.0K | 10% |
| Asset management | $168.0K | 2% |
